ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Weightloss in Menopause

Susan Brian

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard

New Research: Side Effect of GLP1

Susan Brian

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

CKD in Primary Care Full Webinar

Springer Healthcare IME

S. Seidu, B. Itzhak, M. Ungan, L. Moist

An Introduction to Tirzepatide for Weightloss

Susan Brian

Diabetes Burden in Metabolic Syndrome and Obesity

Baylor College of Medicine

E. Trofimovsky

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

How to Prescribe Anti Obesity Medications

Beverly Tchang